Neuropeptide Y-related peptides and their receptors--are the receptors potential therapeutic drug targets?
Neuropeptide Y-related peptides and their receptors--are the receptors potential therapeutic drug targets?
复制标题
DOI:
10.1146/annurev.pa.33.040193.001521
复制
发表时间:
1993
影响因子:
12.5
通讯作者:
Claes Wahlestedt;Donald J. Reis
中科院分区:
文献类型:
--
作者:
Claes Wahlestedt;Donald J. Reis
A decade has passed since the discovery of neuropeptide Y (also known as neuropeptide tyrosine or NPY) by Tatemoto & Mutt (1, 2). This 36-amino-acid peptide, arguably the most abundant and widely distributed of neuropeptides discovered to date, has stimulated several thousand scientific publications . NPY seems to fulfill the main neurotransmitter criteria, since it i s stored in synaptic granulae (3), is released upon electrical nerve stimulation (4 , 5) and acts at specific receptors (e .g . 6). Initially, much NPY-related work concerned its coexistence with classical transmitters (e. g . , norepinephrine) and its possible role in cotransmission; these lines of investigation coincided with the general acceptance that neurons use multiple messenger molecules, at least one of which is commonly a peptide. NPY has been frequently used to study cotransmission, particularly in its relation to the "classical" neurotransmitter norepinephrine, in mediating sympathetic vasoconstriction (6-9) . Although the role of NPY as a modulator of coreleased transmitter remains a focus for many investigators, it has been appreciated that NPY may also be an important messenger in its own right , perhaps particularly in the brain, where NP Y